Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

[Urethral condylomata acuminata].

Brummeisl W, Lausenmeyer E, Weber F, Bründl J, Fritsche HM, Burger M, Denzinger S.

Urologe A. 2015 Mar;54(3):378-84. doi: 10.1007/s00120-014-3619-9. German.

PMID:
25234950
2.

Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.

Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland WF, Giedl C, Hofstädter F, Rubenwolf P, Burger M, Aziz A.

Urol Int. 2014;93(3):311-9. doi: 10.1159/000360483. Epub 2014 Sep 4.

PMID:
25196313
3.

Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study.

Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A, Denzinger S, Fritsche HM, Burger M, Gierth M.

Urol Int. 2015;94(1):37-44. doi: 10.1159/000363334. Epub 2014 Aug 13.

PMID:
25139297
4.

The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.

Mayr R, May M, Burger M, Martini T, Pycha A, Dechet C, Lodde M, Comploj E, Wieland WF, Denzinger S, Otto W, Aziz A, Fritsche HM, Gierth M.

Urol Int. 2014;93(3):303-10. doi: 10.1159/000362421. Epub 2014 Aug 19.

PMID:
25139069
5.

Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.

Aziz A, Rink M, Gakis G, Kluth LA, Dechet C, Miller F, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Fisch M, Burger M, Fritsche HM.

Urol Int. 2014;93(3):352-60. doi: 10.1159/000362248. Epub 2014 Aug 19.

PMID:
25138778
6.

Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.

May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief CG, Bastian PJ, Aziz A.

Ann Surg Oncol. 2014 Nov;21(12):4034-40. doi: 10.1245/s10434-014-3827-y. Epub 2014 Jun 4.

PMID:
24895114
7.

Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.

Aziz A, Fritsche HM, Gakis G, Kluth LA, Hassan Fa, Engel O, Dahlem R, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Shariat SF, Fisch M, Burger M, Rink M.

Urol Oncol. 2014 Nov;32(8):1141-50. doi: 10.1016/j.urolonc.2014.04.008. Epub 2014 May 22.

PMID:
24856977
8.

Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series.

May M, Aziz A, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Fisch M, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief CG, Gilfrich C, Bastian PJ, Engel JB, Burger M, Fritsche HM.

World J Urol. 2015 Mar;33(3):343-50. doi: 10.1007/s00345-014-1308-3. Epub 2014 May 10.

PMID:
24817140
9.

Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer.

Gunia S, Jain A, Albrecht K, Koch S, Otto W, Denzinger S, Götz S, Niessl N, Burger M, May M.

Hum Pathol. 2014 Jun;45(6):1169-76. doi: 10.1016/j.humpath.2014.01.012. Epub 2014 Jan 31.

PMID:
24703102
10.

The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder.

Gierth M, Aziz A, Fritsche HM, Burger M, Otto W, Zeman F, Pawlik MT, Hansen E, May M, Denzinger S.

World J Urol. 2014 Dec;32(6):1447-53. doi: 10.1007/s00345-014-1257-x. Epub 2014 Feb 8.

PMID:
24510120
11.

Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.

Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F; PROMETRICS 2011 research group.

Eur Urol. 2014 Jul;66(1):156-63. doi: 10.1016/j.eururo.2013.12.018. Epub 2013 Dec 27.

PMID:
24388438
12.

Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.

Rose M, Gaisa NT, Antony P, Fiedler D, Heidenreich A, Otto W, Denzinger S, Bertz S, Hartmann A, Karl A, Knüchel R, Dahl E.

Carcinogenesis. 2014 Mar;35(3):727-36. doi: 10.1093/carcin/bgt375. Epub 2013 Nov 21.

13.

Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.

Rubenwolf PC, Otto W, Denzinger S, Hofstädter F, Wieland W, Georgopoulos NT.

World J Urol. 2014 Aug;32(4):991-7.

PMID:
24022233
14.

Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients.

Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F.

Clin Genitourin Cancer. 2013 Dec;11(4):537-44. doi: 10.1016/j.clgc.2013.05.001. Epub 2013 Jul 10.

PMID:
23850551
15.

Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.

Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A, Burger M.

Urol Int. 2013;91(1):97-102. doi: 10.1159/000350232. Epub 2013 Jun 6.

PMID:
23751372
16.

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M.

World J Urol. 2014 Apr;32(2):365-71. doi: 10.1007/s00345-013-1105-4. Epub 2013 Jun 5.

PMID:
23736527
17.

Periostin expression correlates with pT-stage, grading and tumour size, and independently predicts cancer-specific survival in surgically treated penile squamous cell carcinomas.

Gunia S, Jain A, Koch S, Denzinger S, Götz S, Niessl N, May M.

J Clin Pathol. 2013 Apr;66(4):297-301. doi: 10.1136/jclinpath-2012-201262. Epub 2013 Jan 31.

PMID:
23372176
18.

Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.

May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S.

BJU Int. 2013 Aug;112(4):E383-90. doi: 10.1111/j.1464-410X.2012.11735.x. Epub 2013 Jan 10.

PMID:
23305250
19.

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.

Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M.

Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.

PMID:
23217567
20.

What do we do with chronic lymphocytic leukemia with 17p deletion?

Sellner L, Denzinger S, Dietrich S, Glimm H, Merkel O, Dreger P, Zenz T.

Curr Hematol Malig Rep. 2013 Mar;8(1):81-90. doi: 10.1007/s11899-012-0143-0. Review.

PMID:
23188619
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk